UNEXPECTED SEVERE TOXICITY OF CRIZOTINIB IN COMBINATION WITH VINBLASTINE: THE CRISP OPEN-LABEL PHASE 1B TRIAL IN PEDIATRIC PATIENTS WITH ANAPLASTIC LARGE CELL LYMPHOMA (ALCL) (ITCC-053)

PEDIATRIC BLOOD & CANCER(2022)

引用 0|浏览12
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要